# Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

> **NCT04758533** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Hospital Infantil Universitario Niño Jesús, Madrid, Spain** · enrollment: 13 (actual)

## Conditions studied

- Diffuse Intrinsic Pontine Glioma
- Medulloblastoma, Childhood, Recurrent

## Interventions

- **BIOLOGICAL:** AloCELYVIR

## Key facts

- **NCT ID:** NCT04758533
- **Lead sponsor:** Hospital Infantil Universitario Niño Jesús, Madrid, Spain
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-19
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04758533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04758533, "Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04758533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*